HomeAVXL • NASDAQ
add
Anavex Life Sciences Corp
Previous close
$9.02
Day range
$8.60 - $9.20
Year range
$3.25 - $10.45
Market cap
772.49M USD
Avg Volume
1.32M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.20M | 9.54% |
Net income | -12.21M | -8.28% |
Net profit margin | — | — |
Earnings per share | -0.14 | 0.00% |
EBITDA | — | — |
Effective tax rate | 0.55% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 138.76M | -10.37% |
Total assets | 141.54M | -10.31% |
Total liabilities | 11.75M | 6.32% |
Total equity | 129.78M | — |
Shares outstanding | 84.80M | — |
Price to book | 5.90 | — |
Return on assets | -24.83% | — |
Return on capital | -26.82% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -12.21M | -8.28% |
Cash from operations | -5.18M | 32.31% |
Cash from investing | — | — |
Cash from financing | 4.55M | -49.46% |
Net change in cash | -630.00K | -146.67% |
Free cash flow | -1.84M | 58.86% |
About
Founded
2004
Headquarters
Website
Employees
40
